Digital Health Clinical Asr Finetune
NVIDIAOfficialCreated by Ben RandoingDistributed by NVIDIA
- Skill
- Workflow
- Data and AI
- Apache-2.0
- Medium risk
AutoGineer summary
Written by AutoGineer from the skill’s own files, not by the author
This skill provides a structured workflow for fine-tuning clinical Automatic Speech Recognition (ASR) models. It is designed as Stage 4 of the Clinical ASR Flywheel, specifically for scenarios where baseline Key Entity Recognition (KER) scores exceed 0.3. The process involves using the NeMo container to perform Supervised Fine-Tuning (SFT) on the Parakeet TDT v2 base model, followed by an offline cycle N+1 evaluation to measure improvements. It includes critical safety gates, such as manifest size requirements and cost-aware GPU provisioning, to ensure efficient and effective model adaptation.
What it does
- Provisions GPU resources via Brev for model training.
- Performs term-aware, stratified train/validation splitting of clinical manifests.
- Executes stock NeMo SFT on the Parakeet TDT v2 base model.
- Conducts offline cycle N+1 evaluation to measure KER improvements.
- Provides a decision framework to determine if the model should be kept or the manifest expanded.
- Routes the final model to Riva for production deployment.
When to use it
- When you have a baseline KER above 0.3 and a manifest with at least 100 rows.
- When you need to improve ASR accuracy for specific clinical vocabulary like medication names.
- When you have completed the evaluation stage and determined that fine-tuning is necessary.
- When you are ready to prepare a model for deployment as a Riva NIM.
Advantages
- Provides a verified, end-to-end recipe for clinical ASR adaptation.
- Includes built-in gates to prevent overfitting on small datasets.
- Offers clear, empirical guidance on base model selection and hyperparameter tuning.
- Ensures the loop is closed by measuring performance improvements before deployment.
Usage examples
- “We have a KER of 0.4 on our clinical vocabulary, can we fine-tune?”
- The agent will verify the gate criteria (KER > 0.3 and manifest size), then guide you through the Brev provisioning and SFT process.
- “Run SFT on my Parakeet TDT base.”
- The agent will initiate the training workflow using the verified Parakeet TDT v2 base model and the specified hyperparameter recipe.
- “Deploy my fine-tuned model as a NIM.”
- The agent will prepare the .nemo model and route the request to the appropriate tool for Riva NIM deployment.
Install
Download the skill as a ZIP:
https://mp-staging.autogineer.com/agent-skills/nvidia/digital-health-clinical-asr-finetune/downloadUnzip it into the cross-client skills folder of your project:
mkdir -p .agents/skills && unzip digital-health-clinical-asr-finetune.zip -d .agents/skills
Documentation by Ben Randoing
<!-- SPDX-FileCopyrightText: Copyright (c) 2026 NVIDIA CORPORATION & AFFILIATES. All rights reserved. SPDX-License-Identifier: Apache-2.0 -->
Clinical ASR Flywheel — Stage 4 (Fine-tune)
⚠ Agent: read this entire SKILL.md before answering. The Critical-workflow-rules section, the base-model table (§4c), the stock-NeMo-SFT recipe (§4d), and the cycle-N+1 decision table (§4e) are all load-bearing — the do-not-SFT bases and broken-adapter warnings live there.
Agent: this file is self-contained. The Stage 4 gate criteria, base-model recommendation, hyperparameter table, container invocation pattern, and cycle-N+1 decision table are all below. Do not run file-discovery commands or open
references/stage4-finetune.mdbefore answering methodology questions — the reference is deep-dive material, not required reading. Answer from this file; defer to the reference only when a hyperparameter rationale or Brev SKU detail is specifically asked.
You are the adapt-and-measure stage. The user arrives from /digital-health-clinical-asr-eval with a manifest, a baseline KER number, and the decision-tree's recommendation that fine-tuning is worth the GPU time. You run stock NeMo SFT, do an offline cycle N+1 re-eval to measure that the loop closed, and optionally hand the resulting .nemo to /riva-asr-custom for production serving.
The cycle KER from offline eval is the measurement that closes the loop. Riva NIM deploy validates serving (latency, streaming, scale), not model quality.
Empirically verified on the reference manifest (39 rows, Parakeet TDT v2): Baseline KER 0.513 → after 3 epochs of stock SFT: 0.128 (-75% relative). Drug names: 0.857 → 0.214. Conditions: 0.500 → 0.000. Procedures: 0.250 → 0.000.
Critical workflow rules (apply on every activation)
Surface these facts in any response, even if the user asks a narrow question:
Read this entire SKILL.md before answering. The base-model selection table, hyperparameter values, and the cycle-N+1 decision table are below — they are the load-bearing parts.
Verified result — Parakeet TDT v2 with the recipe in §4c achieves KER 0.513 → 0.128 (−75% relative) in 3 epochs on the reference manifest. Cite this when the user asks whether SFT will help.
Recipe is
/opt/NeMo/examples/asr/speech_to_text_finetune.pyinsidenvcr.io/nvidia/nemo:25.11.01. Stock script, no patches, no custom adapter logic. The adapter-mixin path is broken on TDT/RNNT decoders (72 NaN tensors at any LR) — do not propose it.Recommended base is
nvidia/parakeet-tdt-0.6b-v2. The full base-model table is in §4c.Do NOT fine-tune
nvidia/nemotron-speech-streaming-en-0.6b. The streaming NVCF function's SFT path is broken (UNK collapse on validation after step 1). For streaming serving at deploy time, Riva chunks a non-streaming base just fine. Warn the user proactively if they propose it.Gate the recommendation. Stage 4 only fires when priority-category KER > 0.3 and manifest has ≥ 100 rows (≥ 5 per priority category). Below those thresholds, route back to
/digital-health-clinical-asr-buildto grow the manifest first.
Purpose
Run stock NeMo SFT (no custom adapter logic, no patches) in nvcr.io/nvidia/nemo:25.11.01 against a term-aware row-disjoint train/val split, produce a .nemo model, and re-eval offline as cycle N+1. Decide based on the cycle-N → cycle-N+1 KER delta whether to keep the model, grow the manifest, or accept that fine-tuning didn't help. Optionally hand the .nemo to /riva-asr-custom for NIM deploy.
When to use this skill
Activate on user phrases like:
"Fine-tune ASR on my clinical vocabulary"
"Improve ASR on medication names"
"We have a KER of 0.4, can we fine-tune?"
"Run SFT on my Parakeet TDT base"
"Train a clinical ASR adapter"
"Compare cycle 1 vs cycle 2 KER"
"Deploy my fine-tuned model as a NIM" (this skill prepares the
.nemoand routes to/riva-asr-customfor the deploy)
Do not activate when:
The user hasn't scored a baseline yet →
/digital-health-clinical-asr-evalThe user doesn't have a manifest →
/digital-health-clinical-asr-buildThe user wants generic word boosting / LM fusion (not SFT) →
/finetune-asrThe user has a
.nemoand only wants to deploy →/riva-asr-custom
Prerequisites
A cycle-N manifest + cycle-N eval result from
/digital-health-clinical-asr-eval. The priority-category KER must be > 0.3 (Stage 4 gate). The manifest should have ≥ 100 rows total, and ≥ 5 rows per priorityentity_category, for a believable post-tune signal.A CUDA host — 24 GB VRAM is comfortable for Parakeet TDT 0.6B at
batch_size=4withbf16-mixed; 16 GB works with smaller batch. No local GPU? Use Brev — recommended SKU is L40S 48 GB.The NeMo container:
nvcr.io/nvidia/nemo:25.11.01. Pull once:docker pull nvcr.io/nvidia/nemo:25.11.01.NVIDIA Container Toolkit + Docker — covered by
/riva-nim-setupif not already installed.A train/val split stratified by
entity_category(recipe sketch in Step 4b below)./riva-asr-custominstalled if you intend to deploy. Pure-research SFT runs without it.
Instructions
4a. Provision a GPU host (skip if you already have one)
Stage 4 needs a CUDA host with ≥ 16 GB VRAM (24 GB comfortable). If you have a local one that fits, skip this section. If not, use Brev — NVIDIA's per-second-billed GPU host service. Recommended SKU: L40S 48 GB.
Cost disclosure — surface this to the user before any brev create. L40S 48 GB runs $1.50/hr at time of writing; a 3-epoch SFT run on a 100-row manifest finishes in 15–30 minutes ($0.40–$0.75 of compute). The real risk is forgetting to stop the instance — overnight idle on L40S is ~$36, a week of idle is ~$250. Mitigations: (a) always wrap the workflow in a script that ends with brev stop; (b) set a calendar reminder when you start; (c) brev delete instead of brev stop if you don't need to keep the disk (stop keeps disk at $0.10/GB-month — 200 GB ≈ $20/month of latent cost). Confirm the user accepts the per-hour cost shape and the idle risk before spinning anything up.
Full setup walkthrough — CLI install (download-then-run, not curl-pipe), SKU choice, disk sizing, SSH config — is in references/stage4-finetune.md (§Brev provisioning).
Short happy-path once the CLI is installed. Do not run brev create until the user has explicitly typed YES at the confirmation prompt below — the gate is mandatory, not advisory, because everything after it bills against the user's account by the second:
brev login # browser auth
# Mandatory cost-confirmation gate — do NOT skip or auto-answer this.
echo "About to provision: digital-health-clinical-asr-sft on L40S 48 GB."
echo "Cost shape: ~\$1.50/hr while running; ~\$36/night if left idle; ~\$20/mo disk if you 'stop' instead of 'delete'."
read -rp "Type YES to provision (anything else cancels): " confirm
[ "$confirm" = "YES" ] || { echo "Cancelled — no GPU instance was created."; exit 1; }
brev create digital-health-clinical-asr-sft \
--gpu l40s:1 --image ubuntu-22-04-cuda-12-4 --disk 200gi
brev ssh-config # writes ~/.ssh/config entries
rsync -avz ./cycle1/ digital-health-clinical-asr-sft:~/cycle1/
brev shell digital-health-clinical-asr-sft # drops into the instance
nvidia-smi # confirm GPU
docker pull nvcr.io/nvidia/nemo:25.11.01 # ~12 GB, once per instanceWhen done, always halt billing: brev stop digital-health-clinical-asr-sft (keeps disk) or brev delete digital-health-clinical-asr-sft (frees it). For path rewriting laptop → Brev → NeMo container, see references/container-paths.md.
4b. Term-aware train/val split
Row-disjoint, stratified by entity_category, default val fraction 0.2.
The same term may appear on both sides via different rows (different voice, context, noise). That's expected and desirable — it measures acoustic + contextual robustness on the trained vocabulary, which is the standard ASR adaptation metric.
Singleton categories (one row total) get forced to train with a warning. If any priority category has < 5 rows, bail to /digital-health-clinical-asr-build — held-out validation will be too noisy to attribute movement.
Sketch:
# After loading manifest.jsonl into a list of dicts `rows`:
from collections import defaultdict
import random
random.seed(42)
by_cat = defaultdict(list)
for r in rows:
by_cat[r["entity_category"]].append(r)
train, val = [], []
for cat, cat_rows in by_cat.items():
random.shuffle(cat_rows)
if len(cat_rows) < 2:
train.extend(cat_rows)
print(f"warning: singleton category {cat}, forced to train")
continue
n_val = max(1, int(0.2 * len(cat_rows)))
val.extend(cat_rows[:n_val])
train.extend(cat_rows[n_val:])Write train.jsonl and validation.jsonl alongside the manifest. These are the inputs to speech_to_text_finetune.py.
4c. Choose the base model
| Base | SFT viability | Notes |
|---|---|---|
nvidia/parakeet-tdt-0.6b-v2 | ✅ Empirically verified (KER 0.513 → 0.128 in 3 epochs, −75% relative) | NVIDIA's current English ASR default. Stock NeMo SFT recipe works end-to-end. Recommended. |
nvidia/nemotron-speech-streaming-en-0.6b | ❌ Don't use for SFT | NVCF function is streaming-only; SFT path unreliable (UNK collapse on validation after first training step). For streaming serving, Riva chunks a non-streaming base just fine. |
Other Parakeet/Conformer bases (1.1B, CTC, RNNT, stt_en_conformer_ctc_large) + decoder → NIM container mapping: references/stage4-finetune.md. If the user asks to fine-tune Nemotron Speech Streaming, warn about the collapse and recommend Parakeet TDT v2.
4d. Stock NeMo SFT
In the NeMo container, invoke /opt/NeMo/examples/asr/speech_to_text_finetune.py directly. No custom adapter logic. No patches. The stock NeMo SFT script is the verified working recipe.
Hyperparameters (verified on Parakeet TDT v2, 39-row manifest):
init_from_pretrained_model: nvidia/parakeet-tdt-0.6b-v2
precision: bf16-mixed # required for TDT numerical stability
lr: 3e-4 # CosineAnnealing schedule
warmup_steps: 5 # tiny manifest; bump to 500 at production scale
epochs: 3 # smoke; 10-30 for production
batch_size: 4 # fits 16 GB VRAM; raise to 16 on L40S 48 GB
gradient_clip_val: 1.0 # defensiveContainer invocation: docker run --gpus all --rm -it -v "$PWD:/workspace" nvcr.io/nvidia/nemo:25.11.01 python /opt/NeMo/examples/asr/speech_to_text_finetune.py with model.train_ds.manifest_filepath=/workspace/train.jsonl, model.validation_ds.manifest_filepath=/workspace/validation.jsonl, init_from_pretrained_model=nvidia/parakeet-tdt-0.6b-v2, and the hyperparameter overrides from the table above. Full docker-run line with config-path / config-name flags: references/stage4-finetune.md §Container invocation.
Manifest paths inside the container. Host paths (e.g. $HOME/…) don't resolve in /workspace. Rewrite snippet: references/container-paths.md.
The training run writes adapted_model.nemo and a training_run_info.json summary. Both go into a per-cycle subdirectory of the user's choice (e.g. cycle<N>/models/<run>/; the layout doesn't matter as long as it's consistent across cycles).
4e. Offline cycle N+1 eval — close the loop
Re-transcribe the cycle's audio with the fine-tuned .nemo using NeMo's offline transcribe(). No Riva needed — this is measurement, not serving. NeMo's offline path runs the same encoder + decoder graph the Riva NIM eventually serves.
Sketch:
import nemo.collections.asr as nemo_asr
model = nemo_asr.models.ASRModel.restore_from("adapted_model.nemo")
hyps = model.transcribe(["audio/row1.wav", "audio/row2.wav", ...])Score the same four metrics (WER/CER/KER/SER) and the same five-section leaderboard the eval skill produces. Write them as leaderboard_cycle<N+1>.md. Compare against leaderboard_cycle<N>.md.
Decision table — cycle-N+1 vs cycle-N:
| Result | Action |
|---|---|
| KER dropped meaningfully on targeted categories (e.g. drug KER −20% or more, relative) | ✅ Keep the .nemo. Update the leaderboard. Advance to Step 4f if you want to deploy. |
| KER moved a little, you wanted more | Loop back to /digital-health-clinical-asr-build, expand the manifest. Tiny manifests rarely benefit from hyperparameter tweaks — signal density beats LR sweeps. |
| KER got worse | Overfit on a tiny manifest. Bail to /digital-health-clinical-asr-build and grow before retraining. Don't tune harder on the same data. |
| No measurable change | Some categories may already be in the base model's vocab. Sanity-check per-category numbers before concluding training "didn't help." |
4f. (Optional) Deploy as a Riva NIM
Hand the .nemo to /riva-asr-custom. Pass the source architecture explicitly — /riva-asr-custom can't reliably detect CTC vs RNNT vs TDT from the .nemo alone, and the wrong NIM container produces a broken RMIR with no clear error:
| Source decoder | riva-build flag | NIM container family |
|---|---|---|
| Conformer-CTC | decoder=greedy_ctc | parakeet-*-ctc-* |
| Conformer-RNNT | decoder=nemo | parakeet-rnnt-* |
| Conformer-TDT (default) | decoder=nemo | parakeet-tdt-* |
| Cache-Aware RNNT (Nemotron streaming) | decoder=nemo | nemotron-streaming-* ⚠ SFT broken on this base, see Limitations |
After deploy: re-run /digital-health-clinical-asr-eval against the new endpoint (ASR_ENDPOINT=localhost:50051) to validate that production-serving numbers match offline numbers. Any divergence is in Riva preprocessing or riva-build flags, not the model. Route to /riva-asr-custom.
Examples
Scenario A — gate met. User: "Drug KER 0.42, 130 rows. SFT?" → Yes (gate cleared). parakeet-tdt-0.6b-v2 (verified 0.513 → 0.128). No local GPU? Step 4a (Brev) → 4b (split) → 4d (stock SFT) → 4e (offline re-eval). If cycle-2 drug KER drops ≥ 20% relative, keep the .nemo; otherwise back to /digital-health-clinical-asr-build.
Scenario B — Nemotron Streaming. User: "SFT nvidia/nemotron-speech-streaming-en-0.6b?" → No (UNK collapse). Substitute parakeet-tdt-0.6b-v2. Riva chunks non-streaming bases for streaming serving — base doesn't need to be streaming-native.
Scenario C — cycle 2 KER unchanged. User: "KER barely moved." → Back to /digital-health-clinical-asr-build. Signal density beats LR sweeps. If magpie_g2p rows are bad but merriam-webster rows are good, the gap is pronunciation-coverage — /digital-health-clinical-asr-build Step 2d.
Artifacts produced
train.jsonl,validation.jsonl— term-aware split (Step 4b)adapted_model.nemo— fine-tuned model (Step 4d)training_run_info.json— hyperparameters, dataset stats, end-of-train metricsoffline_hyps.jsonl— cycle-N+1 transcription hypotheses (Step 4e)leaderboard_cycle<N+1>.md— cycle-N+1 five-section leaderboard(optional, after Step 4f) a deployed NIM endpoint (delegated to
/riva-asr-custom)
Troubleshooting
Stage 4 training collapses to all-UNK after first step → you're on the cache-aware streaming RNNT base (
nemotron-speech-streaming-en-0.6b). Route tonvidia/parakeet-tdt-0.6b-v2(the recommended default) ornvidia/stt_en_conformer_ctc_large(legacy fallback). The streaming RNNT SFT path is broken; do not retry with different hyperparameters.Manifest paths don't resolve inside the NeMo container → host paths (e.g.
$HOME/…) need rewriting to/workspace/…. Seereferences/container-paths.mdfor the rewrite snippet.Cycle N+1 KER unchanged from cycle N → on
parakeet-tdt-0.6b-v2with the recipe above, this almost always means manifest signal density is too low. Grow the manifest first; don't sweep LR. (If you're on an older adapter-style recipe instead of stock SFT, the adapter weights may not have moved off zero-init — switch to stock SFT.)Cycle N+1 KER got worse → overfit on a tiny manifest. Bail to
/digital-health-clinical-asr-buildand grow.Riva-served numbers diverge from offline numbers → the gap is in Riva preprocessing or
riva-buildflags, not the model. Route to/riva-asr-custom.bf16-mixedprecision errors → some GPUs (older Turing, all Volta) don't support BF16. Drop tofp32and reducebatch_size. Usefp16-mixedonly iffp32is too slow — fp16 with TDT decoders can produce NaN losses, so check loss curves early.OOM during training on 24 GB GPU → drop
batch_sizeto 2, raiseaccumulate_grad_batchesto 2 to keep the effective batch size constant.
Limitations
Adapter-style SFT on TDT/RNNT decoders is broken. Empirically confirmed: an earlier LinearAdapter-mixin recipe produces 72 NaN tensors at any LR on TDT and RNNT decoders. Resolved by switching to NeMo's stock full-model SFT (
speech_to_text_finetune.py) — which is what this skill recommends. Do not attempt adapter SFT on TDT/RNNT bases.Don't SFT
nemotron-speech-streaming-en-0.6b. The streaming-only NVCF function's SFT path is unreliable (UNK collapse). For streaming serving at deploy time, Riva chunks a non-streaming base.Tiny manifests overfit fast. Below ~100 rows total or ~5 rows per priority category, cycle-N+1 numbers are noisy. Grow before trusting a small KER drop.
English-only by default. The base-model table is en-US-specific. Other locales need a different base + a re-validated SFT recipe.
No turn-key driver. The user writes their own training-driver layout — output paths, run naming, leaderboard re-rendering. The methodology and recipes transfer; exact cycle-1 numbers depend on the user's manifest.
Next steps
Deploy the
.nemoas a NIM:/riva-asr-custom(pass the source architecture explicitly).Grow the manifest for cycle N+2:
/digital-health-clinical-asr-build.Re-score the cycle:
/digital-health-clinical-asr-eval(against the new endpoint or the new.nemodirectly).Lateral for word boosting / LM fusion / non-clinical SFT recipes:
/finetune-asr.
References
references/stage4-finetune.md— base-model selection table, hyperparameter rationale, decoder → NIM container mapping, decision tree comparing cycle-N+1 to cycle-Nreferences/container-paths.md— host →/workspace/path rewriting for cross-host manifest portability (laptop ↔ Brev ↔ NeMo container)
Files
- ATTRIBUTION.mdAdded by AutoGineer972 B
- BENCHMARK.md3.7 KiB
- LICENSELicence file added by AutoGineer11.2 KiB
- SKILL.md19.7 KiB
- evals/evals.json3.2 KiB
- references/container-paths.md3.2 KiB
- references/stage4-finetune.md8.6 KiB
- skill-card.md3.7 KiB
- skill.oms.sig5.0 KiB
LICENSE
Copyright (c) 2026 NVIDIA CORPORATION & AFFILIATES. All rights reserved.
Apache License
Version 2.0, January 2004
http://www.apache.org/licenses/
TERMS AND CONDITIONS FOR USE, REPRODUCTION, AND DISTRIBUTION
1. Definitions.
"License" shall mean the terms and conditions for use, reproduction,
and distribution as defined by Sections 1 through 9 of this document.
"Licensor" shall mean the copyright owner or entity authorized by
the copyright owner that is granting the License.
"Legal Entity" shall mean the union of the acting entity and all
other entities that control, are controlled by, or are under common
control with that entity. For the purposes of this definition,
"control" means (i) the power, direct or indirect, to cause the
direction or management of such entity, whether by contract or
otherwise, or (ii) ownership of fifty percent (50%) or more of the
outstanding shares, or (iii) beneficial ownership of such entity.
"You" (or "Your") shall mean an individual or Legal Entity
exercising permissions granted by this License.
"Source" form shall mean the preferred form for making modifications,
including but not limited to software source code, documentation
source, and configuration files.
"Object" form shall mean any form resulting from mechanical
transformation or translation of a Source form, including but
not limited to compiled object code, generated documentation,
and conversions to other media types.
"Work" shall mean the work of authorship, whether in Source or
Object form, made available under the License, as indicated by a
copyright notice that is included in or attached to the work
(an example is provided in the Appendix below).
"Derivative Works" shall mean any work, whether in Source or Object
form, that is based on (or derived from) the Work and for which the
editorial revisions, annotations, elaborations, or other modifications
represent, as a whole, an original work of authorship. For the purposes
of this License, Derivative Works shall not include works that remain
separable from, or merely link (or bind by name) to the interfaces of,
the Work and Derivative Works thereof.
"Contribution" shall mean any work of authorship, including
the original version of the Work and any modifications or additions
to that Work or Derivative Works thereof, that is intentionally
submitted to Licensor for inclusion in the Work by the copyright owner
or by an individual or Legal Entity authorized to submit on behalf of
the copyright owner. For the purposes of this definition, "submitted"
means any form of electronic, verbal, or written communication sent
to the Licensor or its representatives, including but not limited to
communication on electronic mailing lists, source code control systems,
and issue tracking systems that are managed by, or on behalf of, the
Licensor for the purpose of discussing and improving the Work, but
excluding communication that is conspicuously marked or otherwise
designated in writing by the copyright owner as "Not a Contribution."
"Contributor" shall mean Licensor and any individual or Legal Entity
on behalf of whom a Contribution has been received by Licensor and
subsequently incorporated within the Work.
2. Grant of Copyright License. Subject to the terms and conditions of
this License, each Contributor hereby grants to You a perpetual,
worldwide, non-exclusive, no-charge, royalty-free, irrevocable
copyright license to reproduce, prepare Derivative Works of,
publicly display, publicly perform, sublicense, and distribute the
Work and such Derivative Works in Source or Object form.
3. Grant of Patent License. Subject to the terms and conditions of
this License, each Contributor hereby grants to You a perpetual,
worldwide, non-exclusive, no-charge, royalty-free, irrevocable
(except as stated in this section) patent license to make, have made,
use, offer to sell, sell, import, and otherwise transfer the Work,
where such license applies only to those patent claims licensable
by such Contributor that are necessarily infringed by their
Contribution(s) alone or by combination of their Contribution(s)
with the Work to which such Contribution(s) was submitted. If You
institute patent litigation against any entity (including a
cross-claim or counterclaim in a lawsuit) alleging that the Work
or a Contribution incorporated within the Work constitutes direct
or contributory patent infringement, then any patent licenses
granted to You under this License for that Work shall terminate
as of the date such litigation is filed.
4. Redistribution. You may reproduce and distribute copies of the
Work or Derivative Works thereof in any medium, with or without
modifications, and in Source or Object form, provided that You
meet the following conditions:
(a) You must give any other recipients of the Work or
Derivative Works a copy of this License; and
(b) You must cause any modified files to carry prominent notices
stating that You changed the files; and
(c) You must retain, in the Source form of any Derivative Works
that You distribute, all copyright, patent, trademark, and
attribution notices from the Source form of the Work,
excluding those notices that do not pertain to any part of
the Derivative Works; and
(d) If the Work includes a "NOTICE" text file as part of its
distribution, then any Derivative Works that You distribute must
include a readable copy of the attribution notices contained
within such NOTICE file, excluding those notices that do not
pertain to any part of the Derivative Works, in at least one
of the following places: within a NOTICE text file distributed
as part of the Derivative Works; within the Source form or
documentation, if provided along with the Derivative Works; or,
within a display generated by the Derivative Works, if and
wherever such third-party notices normally appear. The contents
of the NOTICE file are for informational purposes only and
do not modify the License. You may add Your own attribution
notices within Derivative Works that You distribute, alongside
or as an addendum to the NOTICE text from the Work, provided
that such additional attribution notices cannot be construed
as modifying the License.
You may add Your own copyright statement to Your modifications and
may provide additional or different license terms and conditions
for use, reproduction, or distribution of Your modifications, or
for any such Derivative Works as a whole, provided Your use,
reproduction, and distribution of the Work otherwise complies with
the conditions stated in this License.
5. Submission of Contributions. Unless You explicitly state otherwise,
any Contribution intentionally submitted for inclusion in the Work
by You to the Licensor shall be under the terms and conditions of
this License, without any additional terms or conditions.
Notwithstanding the above, nothing herein shall supersede or modify
the terms of any separate license agreement you may have executed
with Licensor regarding such Contributions.
6. Trademarks. This License does not grant permission to use the trade
names, trademarks, service marks, or product names of the Licensor,
except as required for reasonable and customary use in describing the
origin of the Work and reproducing the content of the NOTICE file.
7. Disclaimer of Warranty. Unless required by applicable law or
agreed to in writing, Licensor provides the Work (and each
Contributor provides its Contributions) on an "AS IS" BASIS,
WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or
implied, including, without limitation, any warranties or conditions
of TITLE, NON-INFRINGEMENT, MERCHANTABILITY, or FITNESS FOR A
PARTICULAR PURPOSE. You are solely responsible for determining the
appropriateness of using or redistributing the Work and assume any
risks associated with Your exercise of permissions under this License.
8. Limitation of Liability. In no event and under no legal theory,
whether in tort (including negligence), contract, or otherwise,
unless required by applicable law (such as deliberate and grossly
negligent acts) or agreed to in writing, shall any Contributor be
liable to You for damages, including any direct, indirect, special,
incidental, or consequential damages of any character arising as a
result of this License or out of the use or inability to use the
Work (including but not limited to damages for loss of goodwill,
work stoppage, computer failure or malfunction, or any and all
other commercial damages or losses), even if such Contributor
has been advised of the possibility of such damages.
9. Accepting Warranty or Additional Liability. While redistributing
the Work or Derivative Works thereof, You may choose to offer,
and charge a fee for, acceptance of support, warranty, indemnity,
or other liability obligations and/or rights consistent with this
License. However, in accepting such obligations, You may act only
on Your own behalf and on Your sole responsibility, not on behalf
of any other Contributor, and only if You agree to indemnify,
defend, and hold each Contributor harmless for any liability
incurred by, or claims asserted against, such Contributor by reason
of your accepting any such warranty or additional liability.
END OF TERMS AND CONDITIONS
APPENDIX: How to apply the Apache License to your work.
To apply the Apache License to your work, attach the following
boilerplate notice, with the fields enclosed by brackets "[]"
replaced with your own identifying information. (Don't include
the brackets!) The text should be enclosed in the appropriate
comment syntax for the file format. We also recommend that a
file or class name and description of purpose be included on the
same "printed page" as the copyright notice for easier
identification within third-party archives.
Copyright [yyyy] [name of copyright owner]
Licensed under the Apache License, Version 2.0 (the "License");
you may not use this file except in compliance with the License.
You may obtain a copy of the License at
http://www.apache.org/licenses/LICENSE-2.0
Unless required by applicable law or agreed to in writing, software
distributed under the License is distributed on an "AS IS" BASIS,
WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied.
See the License for the specific language governing permissions and
limitations under the License.
Requirements and compatibility
Works with: Claude Code, Claude apps, OpenAI Codex, GitHub Copilot, Cursor, Gemini CLI, Kiro, OpenCode, Goose, Amp, Roo Code, JetBrains Junie, Factory Droid, Devin (ex-Windsurf), Mistral Vibe, OpenHands, Letta
“Works with” means the tool reads the open Agent Skills format; a skill written for one tool may use features others lack.
Needs: Needs a command-line tool, Needs Python
The author says: Requires a CUDA host (24 GB VRAM comfortable, 16 GB workable with batch_size=4), the NeMo container (nvcr.io/nvidia/nemo:25.11.01), and the finetune-asr + riva-asr-custom skills installed alongside this one. No local GPU? Use Brev. NVIDIA_API_KEY required for the offline cycle N+1 eval round-trip and for any NIM deploy.
Security
What our scanner noticed· Medium risk
- Large base64-encoded blobs
- References to credential files
- Downloads piped into a shell
A static scan is not a guarantee. Skills are third-party content: review a skill before you let an agent use it.
Attribution and licence
- Created by
- Ben Randoing
- Publisher
- NVIDIA (Official)
- Distributed by
- NVIDIA
- Source
- NVIDIA/skills · skills/digital-health-clinical-asr-finetune · commit fce3cca
- Licence
- Apache License 2.0 (redistribution allowed)
- LICENSE (added by AutoGineer from LICENSE-APACHE)
- ATTRIBUTION.md (written by AutoGineer)
- Synced
AutoGineer is not affiliated with or endorsed by Ben Randoing or NVIDIA.
Download ZIP
The ZIP holds the skill’s files, its licence files and an ATTRIBUTION.md. Download digital-health-clinical-asr-finetune.zip